FDA Inspection
F. M. Howell & Company Inc.F. M. Howell & Company Inc. – FDA Inspection, Oct 10, 2025
Record Details
This FDA Inspection record concerns F. M. Howell & Company Inc., with an inspection on October 10, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · e008b577-8d04-47d8-96bd-5b1de0ff6ffe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1286922
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of F. M. Howell & Company Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 22, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2020 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 2, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 2, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 8, 2008 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for F. M. Howell & Company Inc.
- FDA Inspection 1160751 - 2021-12-22
- FDA Inspection 1130441 - 2020-09-08
- FDA Inspection 1002005 - 2016-11-02
- FDA Inspection 766303 - 2012-02-02
- FDA Inspection 542345 - 2008-10-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.